Comparative Pharmacology
Head-to-head clinical analysis: CYCLOCORT versus FLEXICORT.
Peer-Reviewed Evidence
Head-to-head clinical analysis: CYCLOCORT versus FLEXICORT.
CYCLOCORT vs FLEXICORT
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Topical corticosteroid with anti-inflammatory, antipruritic, and vasoconstrictive actions. Suppresses cytokine production, inhibits phospholipase A2, and reduces prostaglandin synthesis.
FLEXICORT contains the active ingredient prednisolone, a corticosteroid that binds to the glucocorticoid receptor, leading to modulation of gene expression, inhibition of phospholipase A2, and suppression of inflammatory mediators such as prostaglandins and leukotrienes.
Apply a thin film topically to affected area twice daily (morning and evening). Not for ophthalmic use.
Flexicort is not a recognized drug name in authoritative pharmacological databases. Please verify the correct generic name. Assuming hydrocortisone: Typical adult dose is 10-40 mg orally daily in divided doses or as a single morning dose. Route: oral. Frequency: once or twice daily.
None Documented
None Documented
3.5 hours (terminal); clinical effect duration longer due to tissue binding.
8–12 hours; clinical context: once-daily dosing maintains therapeutic levels, with steady-state achieved within 2–3 days.
Primarily hepatic metabolism; inactive metabolites excreted renally (<1% unchanged) and in feces (biliary).
Renal excretion of inactive metabolites accounts for 95% of elimination; biliary/fecal excretion is minimal at 5%.
Category C
Category C
Topical Corticosteroid
Topical Corticosteroid